Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.58 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | HTR7 | P34969 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 3/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601373 | 0.90 | ALDH1A1 (0.58) | ALDH1A1TRIM24TRIM33SMN1; SMN2KDM4E | |
| SCHEMBL28367239 | 0.88 | ALDH1A1 (0.49) | ALDH1A1TRIM24TRIM33SMN1; SMN2KDM4E | |
| SCHEMBL28367241 | 0.88 | ALDH1A1 (0.49) | ALDH1A1TRIM24TRIM33SMN1; SMN2KDM4E | |
| SCHEMBL9354477 | 0.85 | ALDH1A1 (0.53) | ALDH1A1TRIM24TRIM33SMN1; SMN2KDM4E | |
| SCHEMBL19601242 | 0.83 | ALDH1A1 (0.57) | ALDH1A1TRIM24TRIM33SMN1; SMN2KDM4E | |
| SCHEMBL1983610 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TRIM24TRIM33SMN1; SMN2KDM4E | |
| SCHEMBL3077544 | 0.82 | TRIM24 (0.83) | ALDH1A1TRIM24TRIM33SMN1; SMN2KDM4E | |
| SCHEMBL2561698 | 0.82 | TRIM24 (0.83) | ALDH1A1TRIM24TRIM33SMN1; SMN2KDM4E | |
| SCHEMBL377522 | 0.81 | ALDH1A1 (0.63) | ALDH1A1TRIM24TRIM33SMN1; SMN2KDM4E | |
| SCHEMBL15768383 | 0.80 | PKM (0.53) | ALDH1A1KDM4EMEN1KMT2ASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552779-B2 | 1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and derivative thereof, preparation method therefor, and composition comprising same for preventing, alleviating or treating neurodegenerative diseases | DUKSUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2026-02-17 | — | — | US | disclosed |
| US-20240358679-A1 | PHARMACEUTICAL AND FOOD COMPOSITIONS FOR THE PREVENTION, ALLEVIATION, OR TREATMENT OF INFLAMMATORY DISEASES COMPRISING 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDIN-4-ONE AND ITS DERIVATIVES | INDUSTRY ACADEMIC COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY (KR) | 2024-10-31 | — | — | US | disclosed |
| US-20230286956-A1 | 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDINE-4-ON AND DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR PREVENTING, ALLEVIATING OR TREATING NEURODEGENERATIVE DISEASES | KNU- INDUSTRY COOPERATION FOUNDATION (KR) | 2023-09-14 | — | — | US | disclosed |
| WO-2023132681-A1 | PHARMACEUTICAL COMPOSITION AND FOOD COMPOSITION COMPRISING 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDIN-4-ONE AND DERIVATIVE THEREOF FOR PREVENTION, ALLEVIATION, OR TREATMENT OF INFLAMMATORY DISEASE | 덕성여자대학교 산학협력단 | 2023-07-13 | — | — | WO | disclosed |
| EP-4183776-A1 | 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDINE-4-ON AND DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR PREVENTING, ALLEVIATING OR TREATING NEURODEGENERATIVE DISEASES | Duksung Women's University Industry-Academic Cooperation Foundation (KR) | 2023-05-24 | — | — | EP | disclosed |
| EP-3481824-B1 | 2-PHENYLIMIDAZO[4,5-B]PYRIDIN-7-AMINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY | KANCERA AB (SE) | 2021-10-20 | — | — | EP | disclosed |
| CN-109563092-B | 2-phenylimidazo [4,5-B ] pyridin-7-amine derivatives useful as inhibitors of the activity of the mammalian tyrosine kinase ROR1 | 坎塞拉有限公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-104693199-A | 2,9-bis-styryl substituted phenanthroline compounds, and preparation method and application thereof | CHINESE ACAD INST CHEMISTRY | 2015-06-10 | — | — | CN | disclosed |
| EP-1831168-B1 | PYRID-2-ONES USEFUL AS INHIBITORS OF TEC FAMILY PROTEIN KINASES FOR THE TREATMENT OF INFLAMMATORY, PROLIFERATIVE AND IMMUNOLOGICALLY-MEDIATED DISEASES. | VERTEX PHARMA (US) | 2014-07-02 | — | — | EP | disclosed |
| EP-0805814-A1 | POLYMERISABLE OR POLYCONDENSABLE PHOSPHINE OXIDE, POLYMERS OBTAINED THEREFROM, AND USE THEREOF IN NON-LINEAR OPTICS AND ELECTRO-OPTICS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1997-11-12 | — | — | EP | disclosed |
| WO-1996022993-A1 | POLYMERISABLE OR POLYCONDENSABLE PHOSPHINE OXIDE, POLYMERS OBTAINED THEREFROM, AND USE THEREOF IN NON-LINEAR OPTICS AND ELECTRO-OPTICS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1996-08-01 | — | — | WO | disclosed |
| EP-0621962-A1 | FUNCTIONALIZED MEROCYANINE DYES AND POLYMERS INCORPORATING SUCH DYES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-11-02 | — | — | EP | disclosed |
| US-5256784-A | Merocyanine dyes | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-10-26 | — | — | US | disclosed |
| WO-1993015596-A2 | FUNCTIONALIZED MEROCYANINE DYES AND POLYMERS INCORPORATING SUCH DYES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552779-B2 | 1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and derivative thereof, preparation method therefor, and composition comprising same for preventing, alleviating or treating neurodegenerative diseases | SNCA, HTT, PSEN1 | ALDH1A1 516/4885TRIM24 2148/4885TRIM33 3746/4885 |
| US-20230286956-A1 | 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDINE-4-ON AND DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR PREVENTING, ALLEVIATING OR TREATING NEURODEGENERATIVE DISEASES | PSEN2, PARK7, SNCA | ALDH1A1 1091/4885TRIM24 1272/4885TRIM33 2950/4885 |
| US-20240358679-A1 | PHARMACEUTICAL AND FOOD COMPOSITIONS FOR THE PREVENTION, ALLEVIATION, OR TREATMENT OF INFLAMMATORY DISEASES COMPRISING 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDIN-4-ONE AND ITS DERIVATIVES | GPX4, GPX1, SELENOI | ALDH1A1 1204/4885TRIM24 933/4885TRIM33 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.